Isatin-azole hybrids and their anticancer activities.

Volume: 353, Issue: 1, Pages: 1900272
Published: Jan 1, 2020
Abstract
Isatin and azole moieties, which have the ability to form various noncovalent interactions with different therapeutic targets, are common pharmacophores in drug development. Isatin and azole derivatives possess promising in vitro and in vivo anticancer activity, and many of them, such as semaxanib, sunitinib, and carboxyamidotriazole, could be used to treat various cancers. Thus, it is conceivable that hybridization of the isatin moiety with...
Paper Details
Title
Isatin-azole hybrids and their anticancer activities.
Published Date
Jan 1, 2020
Volume
353
Issue
1
Pages
1900272
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.